1. Home
  2. PYXS vs SRL Comparison

PYXS vs SRL Comparison

Compare PYXS & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • SRL
  • Stock Information
  • Founded
  • PYXS 2018
  • SRL 2017
  • Country
  • PYXS United States
  • SRL China
  • Employees
  • PYXS N/A
  • SRL N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • SRL Professional Services
  • Sector
  • PYXS Health Care
  • SRL Consumer Discretionary
  • Exchange
  • PYXS Nasdaq
  • SRL Nasdaq
  • Market Cap
  • PYXS 75.0M
  • SRL 89.5M
  • IPO Year
  • PYXS 2021
  • SRL N/A
  • Fundamental
  • Price
  • PYXS $1.14
  • SRL $5.98
  • Analyst Decision
  • PYXS Strong Buy
  • SRL
  • Analyst Count
  • PYXS 5
  • SRL 0
  • Target Price
  • PYXS $9.00
  • SRL N/A
  • AVG Volume (30 Days)
  • PYXS 706.6K
  • SRL 5.0K
  • Earning Date
  • PYXS 08-13-2025
  • SRL 07-22-2025
  • Dividend Yield
  • PYXS N/A
  • SRL 17.13%
  • EPS Growth
  • PYXS N/A
  • SRL N/A
  • EPS
  • PYXS N/A
  • SRL N/A
  • Revenue
  • PYXS N/A
  • SRL $24,535,042.00
  • Revenue This Year
  • PYXS N/A
  • SRL N/A
  • Revenue Next Year
  • PYXS N/A
  • SRL N/A
  • P/E Ratio
  • PYXS N/A
  • SRL N/A
  • Revenue Growth
  • PYXS N/A
  • SRL N/A
  • 52 Week Low
  • PYXS $0.83
  • SRL $5.70
  • 52 Week High
  • PYXS $5.39
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 51.02
  • SRL 44.71
  • Support Level
  • PYXS $1.04
  • SRL $5.84
  • Resistance Level
  • PYXS $1.24
  • SRL $6.42
  • Average True Range (ATR)
  • PYXS 0.08
  • SRL 0.24
  • MACD
  • PYXS -0.00
  • SRL 0.06
  • Stochastic Oscillator
  • PYXS 53.57
  • SRL 55.56

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: